Literature DB >> 27641484

Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency.

Alexandra F Freeman1, Nirali N Shah2, Mark Parta3, Helen C Su4, Alessandra Brofferio5, Irma Gradus-Pizlo6, Sabah Butty6, Thomas E Hughes7, David E Kleiner8, Daniele Avila9, Theo Heller10, Heidi H Kong11, Steven M Holland12, Dennis D Hickstein9.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27641484      PMCID: PMC5605135          DOI: 10.1016/j.jaip.2016.06.028

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device.

Authors:  Michael Schumm; Peter Lang; Wolfgang Bethge; Christoph Faul; Tobias Feuchtinger; Matthias Pfeiffer; Wichard Vogel; Volker Huppert; Rupert Handgretinger
Journal:  Cytotherapy       Date:  2013-10       Impact factor: 5.414

2.  Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency.

Authors:  Jennifer Cuellar-Rodriguez; Alexandra F Freeman; Jennifer Grossman; Helen Su; Mark Parta; Heardley Murdock; Nirali Shah; Catherine Bollard; Heidi H Kong; Niki Moutsopoulos; Kelly Stone; Juan Gea-Banacloche; Steven M Holland; Dennis D Hickstein
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-27       Impact factor: 5.742

Review 3.  Treosulfan-based conditioning in DOCK8 deficiency: complete lympho-hematopoietic reconstitution with minimal toxicity.

Authors:  Sujal Ghosh; Friedhelm R Schuster; Ilka Fuchs; Hans-Jürgen Laws; Arndt Borkhardt; Roland Meisel
Journal:  Clin Immunol       Date:  2012-10-14       Impact factor: 3.969

4.  DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Authors:  Susanne E Aydin; Sara Sebnem Kilic; Caner Aytekin; Ashish Kumar; Oscar Porras; Leena Kainulainen; Larysa Kostyuchenko; Ferah Genel; Necil Kütükcüler; Neslihan Karaca; Luis Gonzalez-Granado; Jordan Abbott; Daifulah Al-Zahrani; Nima Rezaei; Zeina Baz; Jens Thiel; Stephan Ehl; László Marodi; Jordan S Orange; Julie Sawalle-Belohradsky; Sevgi Keles; Steven M Holland; Özden Sanal; Deniz C Ayvaz; Ilhan Tezcan; Hamoud Al-Mousa; Zobaida Alsum; Abbas Hawwari; Ayse Metin; Susanne Matthes-Martin; Manfred Hönig; Ansgar Schulz; Capucine Picard; Vincent Barlogis; Andrew Gennery; Marianne Ifversen; Joris van Montfrans; Taco Kuijpers; Robbert Bredius; Gregor Dückers; Waleed Al-Herz; Sung-Yun Pai; Raif Geha; Gundula Notheis; Carl-Philipp Schwarze; Betül Tavil; Fatih Azik; Kirsten Bienemann; Bodo Grimbacher; Valerie Heinz; H Bobby Gaspar; Roland Aydin; Beate Hagl; Benjamin Gathmann; Bernd H Belohradsky; Hans D Ochs; Talal Chatila; Ellen D Renner; Helen Su; Alexandra F Freeman; Karin Engelhardt; Michael H Albert
Journal:  J Clin Immunol       Date:  2015-01-28       Impact factor: 8.317

5.  HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.

Authors:  Junichi Sugita; Naomi Kawashima; Tomoaki Fujisaki; Kazuhiko Kakihana; Shuichi Ota; Keitaro Matsuo; Toshihiro Miyamoto; Koichi Akashi; Shuichi Taniguchi; Mine Harada; Takanori Teshima
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-18       Impact factor: 5.742

6.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

7.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

8.  Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency.

Authors:  Sung-Yun Pai; Helen de Boer; Michel J Massaad; Talal A Chatila; Sevgi Keles; Haifa H Jabara; Erin Janssen; Leslie E Lehmann; Rima Hanna-Wakim; Ghassan Dbaibo; Douglas R McDonald; Waleed Al-Herz; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2014-04-01       Impact factor: 10.793

9.  Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.

Authors:  Franco Locatelli; Daniela Pende; Maria C Mingari; Alice Bertaina; Michela Falco; Alessandro Moretta; Lorenzo Moretta
Journal:  Front Immunol       Date:  2013-02-01       Impact factor: 7.561

  9 in total
  10 in total

1.  Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.

Authors:  Susanne E Aydin; Alexandra F Freeman; Waleed Al-Herz; Hamoud A Al-Mousa; Rand K Arnaout; Roland C Aydin; Vincent Barlogis; Bernd H Belohradsky; Carmem Bonfim; Robbert G Bredius; Julia I Chu; Oana C Ciocarlie; Figen Doğu; Hubert B Gaspar; Raif S Geha; Andrew R Gennery; Fabian Hauck; Abbas Hawwari; Dennis D Hickstein; Manfred Hoenig; Aydan Ikinciogullari; Christoph Klein; Ashish Kumar; Marianne R S Ifversen; Susanne Matthes; Ayse Metin; Benedicte Neven; Sung-Yun Pai; Suhag H Parikh; Capucine Picard; Ellen D Renner; Özden Sanal; Ansgar S Schulz; Friedhelm Schuster; Nirali N Shah; Evan B Shereck; Mary A Slatter; Helen C Su; Joris van Montfrans; Wilhelm Woessmann; John B Ziegler; Michael H Albert
Journal:  J Allergy Clin Immunol Pract       Date:  2018-11-02

Review 2.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients.

Authors:  Bethany A Pillay; Danielle T Avery; Joanne M Smart; Theresa Cole; Sharon Choo; Damien Chan; Paul E Gray; Katie Frith; Richard Mitchell; Tri Giang Phan; Melanie Wong; Dianne E Campbell; Peter Hsu; John B Ziegler; Jane Peake; Frank Alvaro; Capucine Picard; Jacinta Bustamante; Benedicte Neven; Andrew J Cant; Gulbu Uzel; Peter D Arkwright; Jean-Laurent Casanova; Helen C Su; Alexandra F Freeman; Nirali Shah; Dennis D Hickstein; Stuart G Tangye; Cindy S Ma
Journal:  JCI Insight       Date:  2019-04-25

4.  Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.

Authors:  Mark Parta; Dianne Hilligoss; Corin Kelly; Nana Kwatemaa; Narda Theobald; Christa S Zerbe; Steven M Holland; Harry L Malech; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2020-04-20       Impact factor: 8.317

5.  Primary Immunodeficiency: New Insights and Practical Clinical Approaches.

Authors:  Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

6.  Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.

Authors:  Alexandra F Freeman; Nada Yazigi; Nirali N Shah; David E Kleiner; Mark Parta; Prescott Atkinson; Theo Heller; Steven M Holland; Stuart S Kaufman; Khalid M Khan; Dennis D Hickstein
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

7.  Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.

Authors:  Nirali N Shah; Alexandra F Freeman; Helen Su; Kristen Cole; Mark Parta; Niki M Moutsopoulos; Safa Baris; Elif Karakoc-Aydiner; Thomas E Hughes; Heidi H Kong; Steve M Holland; Dennis D Hickstein
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-10       Impact factor: 5.742

Review 8.  Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders.

Authors:  Tatyana Gavrilova
Journal:  World J Transplant       Date:  2019-07-31

Review 9.  Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

Authors:  Riccardo Castagnoli; Ottavia Maria Delmonte; Enrica Calzoni; Luigi Daniele Notarangelo
Journal:  Front Pediatr       Date:  2019-08-08       Impact factor: 3.418

Review 10.  Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.

Authors:  Yael Gernez; Mary Grace Baker; Paul J Maglione
Journal:  Transfusion       Date:  2018-12       Impact factor: 3.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.